Joe Moore Psychedelics Today on Leadership, Integration, and the Psychedelic Landscape
Jen Davenport joins Psychedelics Today to interview the CEO and co-founder Joe Moore about the growth of Psychedelics Today, the broader psychedelic ecosystem, and how professionals are beginning to engage with psychedelic ideas. Davenport is the founder of Iron Thread Partners and a graduate of the Vital psychedelic training program. Her work focuses on executive […] The post Joe Moore Psychedelics Today on Leadership, Integration, and the Psychedelic Landscape appeared first on Psychedelics Today.
External link. We are not responsible for the content.
Read more ↗More From Psychedelics Today
Colorado’s Ibogaine Bill Could Be a Landmark — If It Respects the Plant’s Roots
HB26-1325 would create a state-supported ibogaine research program to study addiction and PTSD treatment, including f...
Navigating Colorado’s Regulated Psychedelic Model: Lessons From the Front Lines
Entering the legal, regulated model of psychedelic therapy was the last thing on my mind when I moved to Colorado. I ...
Seeing Through the Veil: Why Psychedelic Experiences Often Feel More Real Than Ordinary Life
Scott Shannon, MD What if classic psychedelic medicines like psilocybin don’t heal primarily by changing brain chemis...
Latest News
MAPS Sends Expert Delegation to United Nations Commission on Narcotic Drugs
Vienna, Austria; March 9, 2026 —The Multidisciplinary Association for Psychedelic Studies (MAPS) will send senior aca...
Will the FDA ever fast-track psychedelic drugs? 5 Questions with drug regulation expert Daniel Eisenkraft Klein
Eisenkraft Klein discusses the FDA’s new accelerated drug review program.
AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal
AtaiBeckley is in structured discussions with pharma companies and royalty investors about a potential partnership fo...
Psilocybin Isn’t Legal Yet. So, Why Are States Writing Laws for It?
PLUS ketamine spoons, sleep tripping, and psilocybin vs. anti-depressants. [...] Read More... The post Psilocybin Isn...
The Therapeutic Potential of Psychedelics in the Treatment of Substance Use Disorders
Substance use disorders (SUDs) remain among the most persistent global public health challenges. Despite decades of p...
A new “magic mushroom” drug could treat depression without psychedelic hallucinations
Scientists are exploring a new way to harness the medical promise of psychedelic compounds without the mind-bending s...